These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 8711501

  • 1. The role of ifosfamide in small cell lung cancer.
    Loehrer PJ.
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ifosfamide in small cell lung cancer.
    Einhorn LH.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):19-21. PubMed ID: 2539644
    [Abstract] [Full Text] [Related]

  • 5. Ifosfamide in the treatment of small cell lung cancer.
    Ettinger DS.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):2-6. PubMed ID: 8677443
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
    Lorigan P, Lee SM, Betticher D, Woodhead M, Weir D, Hanley S, Hardy C, Thatcher N.
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):32-41. PubMed ID: 7610397
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U.
    Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer.
    Park S, Ahn MJ, Ahn JS, Lee J, Hong YS, Park BB, Lee SC, Hwang IG, Park JO, Lim H, Kang WK, Park K.
    Lung Cancer; 2007 Oct; 58(1):116-22. PubMed ID: 17624473
    [Abstract] [Full Text] [Related]

  • 18. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 19. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW, Radiation Therapy Oncology Group 9609.
    J Clin Oncol; 2005 Aug 01; 23(22):4991-8. PubMed ID: 15939930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.